Virtual Rehabilitation in HCT
A Pilot Study of Virtual Rehabilitation After Hematopoietic Cell Transplantation
1 other identifier
interventional
40
1 country
1
Brief Summary
Chronic GVHD (cGVHD) is a major cause of illness in patients who undergo hematopoietic transplantation (HCT). GVHD can affect any organ in the body, can require several years of treatment, and can impact the quality of life (QoL). Physical activity and exercise have been shown to enhance fitness and improve QoL in chronic illnesses including GVHD, however, patients often have barriers to attending sessions including distance, risk of infection, and physical therapists' lack of experience with pediatric patients. The team's goal is to assess whether a virtual rehabilitation program in children post-HCT (including children with chronic GVHD) is feasible and whether its implementation will improve physical functioning and QoL. Patients between the ages of 8 and 23 years who are at least one hundred days post-HCT will be eligible for participation. Patients will have an assessment by a pediatric physical therapist at the time of study entry, at the end of the rehabilitation program, and approximately 3 months later. They will be supplied with some exercise equipment (such as dumbbells and resistance bands). Patients will have twice weekly half-hour one-on-one online sessions with the physical therapist for 12 weeks. Patients will be recruited through the bone marrow transplant clinic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 5, 2023
CompletedFirst Posted
Study publicly available on registry
July 13, 2023
CompletedStudy Start
First participant enrolled
July 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
September 19, 2025
September 1, 2025
4 years
July 5, 2023
September 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Adherence Rate
Percentage of sessions completed per participant. A log will be kept to track the sessions completed by participants during the study participation
Throughout the intervention (up to 16 weeks)
Feasibility of the rehabilitation program
Percentage of patients completing ≥75% of sessions
Up to 4 years
Secondary Outcomes (1)
Change in 6-minute walk test at completion of the rehabilitation program
Baseline and up to 16 weeks
Study Arms (1)
Virtual exercise and rehabilitation program
EXPERIMENTALTrial of exercise and rehabilitation program delivered via a virtual platform for patients undergoing HCT at Children's Healthcare of Atlanta.
Interventions
Participants will have two 30-minute sessions per week for 12 weeks. The program will focus on aerobic exercises and stretching exercises. When applicable, stretching exercises will focus on areas of contractures, and joints with limited range of motion (ROM). Sessions will be completed by a team of Physical Therapists using the established telemedicine platform at Children's Healthcare of Atlanta, as used routinely in the blood and marrow transplant clinic for clinical care (Epic). Adherence to the program will be encouraged during monthly standard clinic visits.
Eligibility Criteria
You may qualify if:
- Recipients between the ages of 8 and 23 years ≥100 days post allogeneic HCT.
- Patients 8-14 years old should have a caregiver willing to assist with the implementation of the exercises during the session
- Patients should have access to devices and a reliable internet connection.
- Patients should be cleared for exercise by their physician
- Patients are eligible to participate regardless of underlying diagnosis, preparative regimen, or graft source.
You may not qualify if:
- Any physical impediment to exercise as evaluated by the treating physician.
- Non-English-speaking patients (due to a lack of available interpreters through the telemedicine platform).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
- Incyte Corporationcollaborator
Study Sites (1)
Children's Healthcare of Atlanta
Atlanta, Georgia, 30322, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Muna Qayed, MD, MsCR
Emory University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 5, 2023
First Posted
July 13, 2023
Study Start
July 31, 2023
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
August 1, 2027
Last Updated
September 19, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share